Acute Toxicities and Early Outcomes of Tandem Autologous Stem Cell Transplantation in Pediatric High-Risk Neuroblastoma: A Multicenter Study.
Hudda Z, Webster A, Anderson E, Badia P, Bagatell R, Bhar S, Bidgoli A, Boyd K, Chaudhury S, Cisneros GS, Craddock J, Davies SM, Desai AV, Drobatz L, Dvorak CC, Elkus H, Fabrizio VA, Foster JH, Fraint E, Freedman JL, Galvez J, Garcia M, Haight A, Higham C, Jodele S, Kamat A, Kaviany S, Lehmann L, Leung K, Lind KT, Llaurador G, Kapadia M, Khazal S, Massi K, Mormann M, Pater L, Rangarajan HG, Rotz S, Sabulski A, Sartain SE, Schoettler ML, Sokol E, Streby KA, Stein M, Verneris MR, Weiss BD, Yazdani S, Zheng D, Dandoy CE.
Hudda Z, et al.
Transplant Cell Ther. 2026 Feb;32(2):199.e1-199.e12. doi: 10.1016/j.jtct.2025.10.022. Epub 2025 Nov 17.
Transplant Cell Ther. 2026.
PMID: 41238193
This study evaluated treatment-related toxicities and day +180 outcomes following tandem ASCT in children with HR-NB. We conducted a multi-institutional (n = 13) retrospective review including pediatric patients with HR-NB scheduled for tandem ASCT between January 2014 and …
This study evaluated treatment-related toxicities and day +180 outcomes following tandem ASCT in children with HR-NB. We conducted a multi-i …